27 employees
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
2018
$41M
from 5 investors over 5 rounds
Mercy BioAnalytics, Inc. raised $41M on April 3, 2023
Investors: Novalis LifeSciences LLC, iSelect Fund, Sozo Ventures, Labcorp and Broadway Angels